Z92.850
Personal history of Chimeric Antigen Receptor T-cell therapy
Clinical Classification Guidelines
Inclusion Terms
- Personal history of CAR T-cell therapy
Medical Intelligence & Overview
The ICD-10 code Z92.850 refers to a patient's personal medical history of undergoing Chimeric Antigen Receptor (CAR) T-cell therapy. This advanced immunotherapy is designed to help the immune system fight certain types of cancers, particularly blood cancers like leukemia and lymphoma. Knowing a patient's history of CAR T-cell therapy is important for healthcare providers when planning future treatments or addressing health concerns, as it can influence medical decisions based on previous treatment responses and potential side effects.
Causes & Symptoms
Clinical Causes: Relapsed or refractory blood cancers such as acute lymphoblastic leukemia (ALL) and certain lymphomas Previous treatment that was ineffective with standard therapies Preference for targeted immunotherapy over traditional chemotherapy
Key Symptoms: Prior medical treatments with CAR T-cell therapy noted in health history Possible side effects experienced during or after CAR T-cell therapy, such as cytokine release syndrome or neurotoxicity (although these are historical events, not current symptoms) Ongoing health monitoring needs related to previous therapy Symptoms of cancer recurrence if applicable
Diagnostic & Treatment
Diagnosis Path: A healthcare provider reviews the patient's medical history, records of previous treatments, and possibly laboratory or imaging tests to confirm a history of CAR T-cell therapy. The diagnosis of having undergone CAR T therapy is based on documented treatment records, and this history is coded under Z92.850 for proper medical documentation and billing.
Treatment Protocols: - Additional therapies as needed based on current health status and treatment history
Clinical Advice & FAQs
Billing Guidance
Is Z92.850 a billable ICD-10 code?
Yes, Z92.850 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z92.850?
Clinical documentation must specify the nature of Personal history of Chimeric Antigen Receptor T-cell therapy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference